BlueLight Therapeutics Inc.

Industry

  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Drug Discovery Technologies

Other Names/Subsidiaries

  • Biodesy, Inc.
See more in Biomedtracker

Latest on BlueLight Therapeutics Inc.

In Vivo

Execs On The Move, August 2017

 
• By Regina Paleski

Company Changes ADENT , John To: Neogen Corp. , CEO (July) From: Animal Health International, CEO Phone: 517-372-9200 ARENA , Paul To: Parallax Health Sciences Inc. , CEO (July) From: Arena

In Vivo

Device/Diagnostics Quarterly Deal Statistics, Q1 2016

 
• By Amanda Micklus and Maureen Riordan

Device Transactions During the first quarter of 2016, device companies raised an aggregate $1.8 billion in financing, a 50% increase over last quarter's $1.2 billion. Debt was the top financing vehicl

Scrip

Venture Funding Deals, February 2016

 
• By Deanna Kamienski, Beth Allan, Amanda Micklus, Steven Muntner, and Maureen Riordan

IN VITRO DIAGNOSTICS bioTheranostics Inc. Late round brings $32mm to bioTheranostics ; company becomes independent Molecular diagnostics firm bioTheranostics Inc. raised $32mm in a late-stage f

Scrip

Life Science Start-Ups: Venture Funding, November 2013

 
• By Deanna Kamienski, Beth Allan, Amanda Micklus, Andrea Mancini, Maureen Riordan, and Theresa Surprenant

IN VITRO DIAGNOSTICS Genetic Analysis AS Genetic Analysis closes $2mm financing Norwegian molecular diagnostics firm Genetic Analysis AS raised $2mm in an early-stage financing to Norsk Innova